1David M,Essayan MD.Molecular mechanisms in allergy and clinical immunology cyclic nucleotidc phosphodlcstcrases[J].Journal of Allergy and Clinical Immunology,2001,108:671-680.
2Soderling SH,Beavo JA.Regulation of cAMP and cGMP signaling:new phosphodiesterases and new functions[J].Current Opinion in Cell Biology,2000,12:174-179.
3Qing Huai,Huanchen Wang,Yingjie Sun,et al.Three-Dimensional structures of PDE4D in complex with Roliprams and implication on inhibitor selectivity[J].Structure,2003,11:865-873.
4Fujlshige K,Kotera J,Michibata H,et al.Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP(PDE10A)[J].The Journal of Biological Chemistry,1999,274: 18438-18445.
5Souness JE,Aldous D,Sargent C.Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiseterase(PDE)type4 inhibitors[J],Immunopharmacology,2000,47:127.
6Bumouf,Pruniaux.Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs [J].Current Pharmaceutical Design,2002,8(14):1255-1296.
7Conti M,Jin SL.The molecular biology of cyclic nucleotidc phosphodiestcrases[J].Progress In Nucleic Acid Research And Molecular Biology,1999,63:1-38.
8Robert Tertya,York-Fong Cheungb,Molten Praestegaarda,et al. Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rollpram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process[J].Cellular Signalling,2003,15:955-971.
9Daguang Wang,Chengjun Deng,Bozena Bugaj-Gaweda,et al.Cloning and characterization of novel PDE4D isoforms PDE4D6 and PDE4D7 [J]. Cellular Signalling,2003,15:883-891.
10Cherry JA,Barbara E Thompson,Vanee Pho.Diaze Pam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDF4A1 and PDE4B3 in the mouse [J].Biochimca et Biophysica Acta(BBA)-Gene Structure and Expression,2001,1518:27-35.
